NKTR
Nektar Therapeutics
Price:  
24.59 
USD
Volume:  
3,845,871.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Fair Value

-2,443.63 %
Upside

What is the fair value of NKTR?

As of 2025-07-02, the Fair Value of Nektar Therapeutics (NKTR) is -576.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 24.59 USD, the upside of Nektar Therapeutics is -2,443.63%.

Is NKTR a good investment?

With the market price of 24.59 USD and our fair value calculation, Nektar Therapeutics (NKTR) is not a good investment. Investing in NKTR stocks now will result in a potential loss of 2,443.63%.

Note: valuation result may not be accurate due to the company's negative EPS.

24.59 USD
Stock Price
-576.30 USD
Fair Price
FAIR VALUE CALCULATION

NKTR Fair Value

Peter Lynch's formula is:

NKTR Fair Value
= Earnings Growth Rate x TTM EPS
NKTR Fair Value
= 18.59 x -31.01
NKTR Fair Value
= -576.30

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -444.40 -523.80 -368.20 -276.06 -118.96 -346.28
YoY growth -0.84% -17.87% 29.71% 25.03% 56.91% 18.59%

NKTR Fair Value - Key Data

Market Cap (mil) 101.97
P/E
Forward P/E
EPS -31.01
Avg earnings growth rate 18.59%
TTM earnings -128.58